Dividend King
搜索文档
The New Tech Dividend King Poised for Explosive Growth
The Motley Fool· 2025-12-17 17:16
This quiet compounder, backed by a solid dividend yield, could see its earnings growth accelerate.Payroll is not a flashy business. But it is a mission-critical one (not to mention a nice contrast to the many hyped-up artificial intelligence-names that have become market darlings in 2025). And that is why Automatic Data Processing (ADP 1.05%) has been able to quietly compound for decades while paying shareholders more every year, turning it into a Dividend King that every investor looking to bolster their p ...
Is It Time to Load Up on This Dividend King Poised to Join the $1 Trillion Club in 2026?
The Motley Fool· 2025-12-17 01:05
The current momentum should carry Walmart into the 13-figure club.For decades, Walmart (WMT 0.74%) has been a retail staple, with more than 10,000 stores across 19 countries. While retail remains its bread and butter, it's approaching the industry from a more modern direction, and it's been paying off for its business and stock.Through Dec. 14, Walmart's stock is up more than 29%, outperforming the S&P 500 and putting the company on a path to join the trillion-dollar market cap club.At the time of this writ ...
1 Stock I'd Buy Before Altria (MO) In 2026
The Motley Fool· 2025-12-16 04:07
Coca-Cola might impress more investors than the tobacco giant next year.Altria (MO +0.70%), the top tobacco company in America, is generally a safe income play for conservative dividend investors. Its flagship Marlboro brand still controls nearly half of the retail cigarette market, and it's expanding its portfolio with more smoke-free products -- like e-cigarettes and nicotine pouches -- as adult smoking rates decline. It also constantly raises its prices, cuts costs, and buys back its shares to boost its ...
Is This 53-Year-Dividend-Streak Stock Due for a 20% Breakout?
The Motley Fool· 2025-12-16 04:05
This Dividend King consumer staples company is working with an activist investor to improve its profitability.Only a small number of companies ever manage to increase their dividends for 50 consecutive years. Reaching Dividend King status is a remarkable achievement, demonstrating both consistency and resilience in the face of adversity.Currently, there's one Dividend King facing some business headwinds, but an activist investor could steer the company in the right direction and help its shareholders with a ...
Here's How Many Shares of Altria You'd Need for $500 in Yearly Dividends
The Motley Fool· 2025-12-15 22:21
It would cost investors a little over $27,000 if they were starting with zero shares.Tobacco giant Altria (MO +0.97%) has routinely held one of the highest dividend yields on the stock market. Its current yield is 7%, which is almost six times higher than the S&P 500 (^GSPC +0.25%) average. Even so, it's below Altria's 7.7% average over the past five years.Altria's annual dividend is $4.24 per share ($1.06 quarterly), meaning you'd need to own 472 shares to receive $500 in annual dividend income. At the tim ...
My Top 3 Healthcare Stocks to Buy in 2026
The Motley Fool· 2025-12-14 03:37
These habitual market beaters can pull it off again.After trailing broader equities over the past few years, will the healthcare sector finally bounce back in 2026? It's hard to predict those things.No matter what happens to the industry, though, there are plenty of excellent healthcare stocks that look attractive heading into the new year. Let's consider three that are among my favorites to buy: AbbVie (ABBV 0.29%), Eli Lilly (LLY +1.80%), and Intuitive Surgical (ISRG 0.88%). 1. A reliable dividend payerOn ...
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026
Yahoo Finance· 2025-12-13 01:43
行业概述 - 尽管今年整体股市表现良好,但部分行业板块表现落后于市场,其当前估值水平显得具有吸引力,医疗保健行业便是其中之一 [1] 艾伯维公司分析 - 艾伯维在2025年股价表现已超越市场,且展望2026年,其股票具有吸引力 [2] - 公司虽在2023年失去了史上最畅销药物修美乐的专利独占权,但已迅速恢复营收增长,产品线更加多元化,对单一药物的销售依赖降低 [4][5] - 公司目前整体更健康、风险更低,至少在2030年前无需面对任何主要产品的专利悬崖,这为其未来规划提供了充足时间 [6] - 公司正通过推进关键产品研发管线、达成重要许可协议及收购来加强业务,战略举措积极 [6] - 公司目标之一是更深入地向其他治疗领域多元化发展,包括肿瘤学,其管线中有多个值得关注的候选药物,如用于治疗转移性前列腺癌的ABBV-969和针对肺癌及头颈癌等的ABBV-514 [7] - 公司通过与丹麦Gubra A/S达成许可协议,获得一款在研减肥药GUB014295,从而进入了快速增长的减肥药市场 [8] - 在未来五年内,公司有望在研发管线和监管审批方面取得重大进展,同时持续产生稳定的收入和收益 [8] - 公司是市场上优质的股息股之一,属于“股息之王”,即已连续至少50年每年增加股息,其长期记录彰显了业务的韧性 [10] 默克公司分析 - 默克公司股价在2025年迄今为负收益,但展望2026年,其股票具有吸引力 [2]
Coca-Cola vs. PepsiCo: Which Is the Better Income Stock?
The Motley Fool· 2025-12-11 22:15
文章核心观点 - 百事公司和可口可乐公司均为连续提高股息超过50年的“股息之王” 但两者为收入型投资者提供的未来前景不同 百事公司在股息增长潜力和收益率方面均优于可口可乐公司 [1][2][13] 股息之王地位与近期股息增长 - 全球近54,000只公开交易股票中 仅有55只达到“股息之王”地位 即连续至少50年提高股息 占比略高于千分之一 [1] - 可口可乐已连续63年提高股息 百事公司则刚宣布其第53次年度股息增长 [2] - 两家公司最近一次股息增幅相近 百事公司为5% 可口可乐为5.2% [2] 股息增长与通胀的比较 - 自2020年以来 通胀率约为25% [5] - 同期 可口可乐股息从每股0.41美元增至0.51美元 增长24.4% 略低于通胀率 [5] - 同期 百事公司股息从每股0.955美元增至1.423美元 增长49% 几乎是通胀率的两倍 [7] 股息可持续性与财务指标分析 - 百事公司股息支付率(净收入用于支付股息的比例)高达105% [8] - 衡量股息可持续性的更好指标是将股息支付额与经营活动现金流进行比较 [9] - 2025年前九个月 百事公司经营活动现金流为54.7亿美元 可口可乐为36.5亿美元 [10] - 下一季度 百事公司计划支付股息19.5亿美元 可口可乐计划支付21.9亿美元 [12] - 百事公司股息支付额仅占其经营活动现金流的36% 而可口可乐则占60% [12] 当前收益率与未来展望 - 百事公司当前股息收益率为3.9% 可口可乐为2.9% [13] - 两家公司的收益率均远高于标普500指数的平均水平 [13] - 基于更高的收益率和更快的股息增长前景 百事公司被认为是更优的选择 [13]
Why ExxonMobil Rallied Today
The Motley Fool· 2025-12-10 02:43
公司股价与市场表现 - 埃克森美孚股价在周二大幅上涨,盘中最高涨幅达4.2%,截至美国东部时间下午12:35,涨幅为2.9%,股价接近52周高点[1] - 公司当前股价为118.59美元,市值为4890亿美元,当日交易区间为116.55美元至120.45美元,52周区间为97.80美元至120.81美元[2] 2030年财务目标更新 - 公司上调了2030年的长期盈利和现金流目标,新目标高于先前指引和分析师预期[1] - 预计到2030年将新增250亿美元的盈利增长,复合年化盈利增长率为13%,同期还将新增350亿美元的现金流增长[3] - 公司预计在不增加额外资本投入的情况下实现此增长,并预计投资资本回报率将达到17%[3] 增长驱动因素与资产优势 - 财务预测的改善完全归因于公司的专有技术,该技术能以更低成本开采更多石油[4] - 关键的增长将来自二叠纪盆地以及圭亚那油气田,公司将这些定义为具有竞争优势的资产[4] - 预计到2030年,包括二叠纪盆地、圭亚那以及液化天然气业务在内的“优势”资产将占总产量的65%[4] - 公司预计,2023年底完成的先锋自然资源收购案所带来的成本协同效应将翻倍[4] - 所有新预测仍基于每桶65美元的油价假设[4] 股息与股东回报 - 公司已连续43年提高股息,鉴于新的盈利增长前景,这一趋势预计将持续到本十年末[5] - 若持续提高股息,公司不久后将实现连续50年股息增长,从而跻身“股息之王”行列,这对能源公司而言尤为罕见[5] - 公司目前的股息收益率为3.45%[2]
If You Bought 10 Shares of Johnson & Johnson 10 Years Ago, You’d Have This Much Today
Yahoo Finance· 2025-12-08 23:07
Hindsight is always 20/20, and nowhere is this more evident than in the stock market. But that doesn’t stop investors from trying to determine what they would have made if they had actually invested in a stock they were considering. With this in mind, if you had bought 10 shares of Johnson & Johnson (JNJ) stock 10 years ago, this is how much it would be worth today. Check Out: I Got Rich Investing — These Lessons for Beginners Could Lead To $1 Million Net Worth Read Next: 6 Safe Accounts Proven To Grow Yo ...